baber/WOPTO huggingface dataset:
Patent CY-1117015-T1 (CY)
Title: 2,4-δι(φαινυλαμινο)-πυριμιδινες χρησιμες στην αντιμετωπιση νεοπλασματικων νοσων, φλεγμονωδων διαταραχων και διαταραχων του ανοσοποιητικου συστηματος
Inventor: GARCIA-ECHEVERRIA CARLOS
IPC: C07D405/14
Filed: 2013-08-13
Abstract: Νέα πυριμιδινικά παράγωγα του τύπου (Ι) και η χρήση τους για την παραγωγή ενός φαρμάκου για την αντιμετώπιση ή πρόληψη μιας νόσου η οποία αποκρίνεται σε αναστολή των FΑΚ και/ή ΑLΚ και/ή ΖΑΡ-70 και/ή ΙGF-ΙR στα οποία: n' επιλέγεται από 1, 2 και 3˙ R'1 επιλέγεται από φαινύλιο, πυριδινύλιο, πυραζολύλιο και πυριμιδινύλιο˙ και R'2 και R'3 είναι όπως περιγράφονται στο παρόν.
Patent CY-1114465-T1 (CY)
Title: Καρεκλα για την εξαλειψη προβληματων καθιστικης προελευσης
Inventor: JALKANEN VELI-JUSSI
IPC: A47C7/14
Filed: 2013-10-09
Abstract: Η παρούσα εφεύρεση σχετίζεται με μια μέθοδο και μια καρέκλα για την εξάλειψη προβλημάτων καθιστικής προέλευσης, στην οποία μέθοδο η λεκάνη καθώς και οι μύες των μηρών του ατόμου που κάθεται στηρίζονται, ενόσω κάθεται μέσω των πλευρικών τμημάτων (3, 5) τα οποία τουλάχιστον εν μέρει καμπυλώνουν με φορά προς τα κάτω σχηματίζοντας ένα τμήμα καθίσματος σχήματος σέλλας. Στη μέθοδο σύμφωνα με την εφεύρεση τα πλευρικά τμήματα (3, 5) του τμήματος του καθίσματος (13) είναι σχηματισμένα από τουλάχιστον δύο τμήματα, ανάμεσα στα οποία ένα κεντρικό άνοιγμα σε επιμήκη διάταξη με το τμήμα του καθίσματος (13) έχει σχηματιστεί.
Patent CY-1115556-T1 (CY)
Title: Φαρμακευτικη συνθεση για χορηγηση απο το στομα η οποια περιλαμβανει ετεξιλικη δαβιγατρανη
Inventor: BRUECK SANDRA
IPC: A61K9/20
Filed: 2014-09-11
Abstract: Η παρούσα εφεύρεση σχετίζεται με μια χορηγούμενη από το στόμα φαρμακευτική σύνθεση η οποία περιλαμβάνει ετεξιλική δαβιγατράνη ή ένα φαρμακευτικά αποδεκτό άλας αυτής ως δραστικό συστατικό.
Patent CY-1115734-T1 (CY)
Title: Συνθεσεις benzenesulfonamide, μεθοδος συνθεσης τους, και χρηση αυτων στην ιατρικη
Inventor: CLARY LAURENCE
IPC: C07D209/10
Filed: 2014-10-03
Abstract: Η παρούσα εφεύρεση αναφέρεται σε νέες συνθέσεις benzenesulfonamides με δομή που αντιστοιχεί στον ακόλουθο γενικό τύπο (I): καθώς και στην διαδικασία της σύνθεσης τους και στην χρήση τους σε φαρμακευτικές συνθέσεις που προορίζονται για χρήση στην ανθρώπινη ιατρική ή κτηνιατρική ή στην χρήση τους σε συνθέσεις καλλυντικών.
Patent CY-1116886-T1 (CY)
Title: C-met αντισωματα
Inventor: DAVIES JULIAN
IPC: A61K39/395
Filed: 2015-10-02
Abstract: Παρέχονται μονόκλωνα αντισώματα, αντιγονο-δεσμευτικά θραύσματα αυτών, και συνδυασμοί των προαναφερθέντων, που δεσμεύονται σε, και αναστέλλουν τη δραστικότητα c-Met, και τα οποία είναι αποτελεσματικά σε αντιμετώπιση καρκίνων και άλλων νόσων, διαταραχών ή παθήσεων όπου η παθογένεση διαμεσολαβείται από c-Met.
Patent CY-1117358-T1 (CY)
Title: ΔΙΑΛΥΤΗ ΓΛΥΚΟΠΡΩΤΕΪΝΗ ΥΑΛΟΥΡΟΝΙΔΑΣΗΣ (sHASEGP), ΔΙΑΔΙΚΑΣΙΑ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΤΗΣ, ΧΡΗΣΕΙΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΛΑΜΒΑΝΟΥΝ
Inventor: BOOKBINDER LOUIS
IPC: A61K47/48
Filed: 2016-03-31
Abstract: Η εφεύρεση αναφέρεται στην ανακάλυψη καινοτόμων διαλυτών ουδέτερων δραστικών Γλυκοπρωτεϊνών Υαλουρονιδάσης (sHASEGP's), μεθόδους για την κατασκευή τους, και στην χρήση τους στην διευκόλυνση της χορήγησης άλλων μορίων ή στην ανακούφιση παθολογικών καταστάσεων που σχετίζονται με τις γλυκοσαμινογλυκάνες. Ελάχιστα δραστικά τμήματα πολυπεπτιδίων των διαλυτών, ουδέτερων δραστικών πεδίων των sHASEGP περιγράφονται, τα οποία περιλαμβάνουν τμήματα σακχάρων που είναι συνδεδεμένα σε ασπαραγινικό που απαιτούνται για ένα λειτουργικό ουδέτερο δραστικό πεδίο υαλουρονιδάσης. Περιλαμβάνονται τροποποιημένες αμινοτελικά καθοδηγητικά πεπτίδια τα οποία ενισχύουν την έκκριση των sHASEGP. Η εφεύρεση περιλαμβάνει επιπλέον σιαλιλυλοποιημένες και πεγκυλιωμένες μορφές μιας ανασυνδυασμένης sHASEGP προκειμένου να ενισχυθεί η σταθερότητα και η φαρμακοκινητική στον ορό στα φυσικώς υπάρχοντα ένζυμα σφαγείου. Περιγράφονται επιπλέον κατάλληλες συνθέσεις μιας σημαντικά καθαρής ανασυνδυασμένης sHASEGP γλυκοπρωτεΐνης που προέρχεται από ένα ευκαρυωτικό κύτταρο που παράγει την κατάλληλη γλυκοσυλίωση που απαιτείται για την βέλτιστη απόδοση της.
Patent CY-1123234-T1 (CY)
Title: Ενας ηλιακος θερμοηλεκτρικος σταθμος και μια μεθοδος λειτουργιας ενος ηλιακου θερμοηλεκτρικου σταθμου
Inventor: IAQUANIELLO GAETANO
IPC: F01K3/24
Filed: 2020-03-04
Abstract: Ένα σύστημα εφεδρικού λέβητα για έναν ηλιακό θερμοηλεκτρικό σταθμό (201) για τη μεταφορά ηλιακής ενέργειας σε ηλεκτρισμό, όπου το εν λόγω σύστημα εφεδρικού λέβητα περιλαμβάνει έναν θάλαμο καύσης (70) και ένα τμήμα συναγωγής (80) σε υγρή σύνδεση με τον εν λόγω θάλαμο καύσης (70), όπου στο τμήμα συναγωγής (80) παρέχεται τουλάχιστον ένας πρώτος εναλλάκτης θερμότητας (92) για τη θέρμανση του μείγματος τετηγμένων αλάτων του ηλιακού θερμοηλεκτρικού σταθμού και ένας δεύτερος εναλλάκτης θερμότητας (90) για την προθέρμανση της τροφοδοσίας του λέβητα (25) διαμορφώνεται, έτσι ώστε να επιτρέπει την επιλογή μεταξύ της παροχής θερμότητας μόνο στον πρώτο εναλλάκτη θερμότητας (92), της παροχής θερμότητας μόνο στον δεύτερο εναλλάκτη θερμότητας (90) και παροχής θερμότητας και στους δυο εναλλάκτες θερμότητας (90, 92), κατά προτίμηση αναλόγως τη διαθεσιμότητα ηλιακής ακτινοβολίας και/ή τη ζήτηση παραγωγής ηλεκτρικής ενέργειας. Η εφεύρεση αναφέρεται επίσης σε έναν ηλιακό θερμοηλεκτρικό σταθμό (201) για τη μεταφορά ηλιακής ενέργειας σε ηλεκτρισμό και μια μέθοδο για τη λειτουργία ενός ηλιακού θερμοηλεκτρικού σταθμού.
Patent CY-1123794-T1 (CY)
Title: ΣΤΕΡΕΑ ΔΙΑΣΠΟΡΑ ΑΜΟΡΦΗΣ ΜΟΡΦΗΣ (R)-l-(2,2-ΔΙΦΘΟΡΟΒΕΝΖΟ[D][1,3]ΔΙΟΞΟΛ-5-ΥΛΟ)-Ν-(1-(2,3-ΔΙΥΔΡΟΞΥΠΡΟΠΥΛΟ)-6-ΦΘΟΡΟ-2-(1-ΥΔΡΟΞΥ-2-ΜΕΘΥΛΟΠΡΟΠΑΝ-2-ΥΛΟ)-1Η-ΙΝΔΟΛ-5-ΥΛΟ)-ΚΥΚΛΟΠΡΟΠΑΝΟΚΑΡΒΟΞΑΜΙΔΙΟΥ
Inventor: KESHAVARZ-SHOKRI ALI
IPC: A61K9/10
Filed: 2021-02-08
Abstract: Η παρούσα εφεύρεση σχετίζεται με στερεά άμορφη μορφή (R)-1 -(2,2-διφθοροβενζο[d[1,3]διοξολ-5-υλο)-Ν-(1-(2,3-διυδροξυπροπυλο)-6-φθορο-2-(1-υδροξυ-2-μεθυλοπροπαν-2-υλο)-1Η-ινδολ-5-υλο)-κυκλοπροπανοκαρβοξαμιδίου (ένωση 1), φαρμακευτικές συνθέσεις αυτού, στερεές διασπορές αυτού και την ένωση 1 για χρήση στην αγωγή μίας νόσου που διαμεσολαβείται από CFTR όπως η κυστική ίνωση.
Patent HR-P20100434-T1 (HR)
Inventor: LIN PIN-FANG
IPC: A61P31/18
Filed: 2010-08-03
Abstract: Uporaba 1-benzoil-4-[2-[4-metoksi-7-(3-metil-1H-1,2,4-triazol-1-il)-1H pirolo [2,3-c] piridin-3-il]-1,2-dioksoetil]-piperazina, ili njegove farmaceutski prihvatljive soli ili solvata, naznačena time što se radi o uporabi za proizvodnju lijeka za liječenje zaraze virusom HIV kod ljudskog bolesnika, s barem još jednim drugim sredstvom za liječenje AIDS-a ili zaraze virusom HIV, izabranim iz skupine koja obuhvaća zalcitabin, emtricitabin, didanozin, tenofovir, stavudin, efavirenz, delavirdin, ritonavir, sakvinavir, enfuvirtid, AMD-3100 i 3-[(4-fluorobenzil)metoksikarbamoil]-2-hidroksiakrilnu kiselinu, ili njihovu farmaceutski prihvatljivu sol ili solvat. Patent sadrži još 9 patentnih zahtjeva.
Patent SI-1334721-T1 (SI)
Title: Nateglinide-containing hydrophilic drug preparations
Inventor: NINOMIYA NOBUTAKA
IPC: A61K9/00
Filed: 2001-10-23
Abstract: There is provided a nateglinide-containing hydrophilic pharmaceutical preparation comprising nateglinide B-type crystals as an effective ingredient, the contact angle of the surface of said preparation to water becoming 111 degree or less by incorporating in said preparation at least one hydrophilic substance selected from the groups consisting of hydrophilic polymers, surfactants, sugars, sugar alcohols and salts. This preparation is one having sufficient immediate-release and high dissolution properties, and can be easily prepared. <IMAGE>
Patent SI-1548845-T1 (SI)
Title: Process for treating of powder particles
Inventor: ALTOSAAR MARE
IPC: H01L31/00
Filed: 2003-12-22
Abstract: To handle powder granules, of a Cu(In,Ga)Se 2 compound, they are placed in a vessel with a volume of sulfur to be heated to bring the powder compound to 400-600[deg]C and the sulfur to 100[deg]C, and the raised temperature is maintained for a time span of 1-50 hours.
Patent SI-1610726-T1 (SI)
Title: Intraocular lens and injector for the same
Inventor: VINCENT PATRICE
IPC: A61F2/00
Filed: 2004-03-26
Abstract: An injectable intraocular lens ( 10 ) made of flexible material, said lens ( 10 ) having an optical portion ( 11 ) that is preferably of approximately circular shape, said injectable intraocular lens being characterized in that it also has two side flats ( 15 ) provided on opposite edges of the optical portion ( 11 ), said flats ( 15 ) forming an angle relative to each other.
Patent SI-1962572-T1 (SI)
Title: A germinating unit as well as a seed tape including several of such germinating units successively arranged
Inventor: AHM POUL HENRIK
IPC: A01C1/00
Filed: 2006-12-06
Abstract: A germinating unit (1) includes at least one seed (3) as well as additives. The germinating unit includes a carrier material (2) penetrable by a root tip (4) and/or a sprout (5) extending from the seed. The carrier material (2) can fix the orientation of the seed. Several germinating units can be joined to form a seed tape (6). The seed tape includes a longitudinal tissue (7). The carrier material portions (2a, 2b, 2c) cover or include their respective seed(s) (3a, 3b, 3c). When the seed(s) have been inserted in the carrier material through a cut in said carrier material or through insertion of a tube therein, said seed(s) maintain(s) its/their position relative to the germinating unit because said carrier material squeezes about or retains said seed(s).
Patent SI-2425815-T1 (SI)
Title: Stabilized pharmaceutical sub-micron suspensions and methods of forming same
Inventor: CASTILLO ERNESTO J
IPC: A61K47/00
Filed: 2009-09-16
Abstract: The present invention is directed to a pharmaceutical submicron suspension and a method of forming the submicron suspension. The submicron suspension is useful for delivery of relatively hydrophobic and/or low solubility therapeutic agent. The submicron suspension and method of forming the submicron suspension typically employ a polymeric material that aids in preventing aggregation of the therapeutic agent.
Patent SI-2696889-T1 (SI)
Title: Variants of human gdnf
Inventor: LEUNG DONMIENNE DOEN MUN
IPC: C07K14/00
Filed: 2012-04-03
Abstract: The present invention relates to novel variants of human glial cell-derived neurotrophic factor (GDNF) and methods for their use.
Patent DE-3586304-T2 (DE)
Inventor: KAWASAKI GLENN
IPC: C07K14/395
Filed: 1985-05-24
Granted: 1992-12-10
Abstract: Methods are provided for producing protein products in host cells and for selecting transformed cells comprising the step of transforming the host cell with a DNA molecule comprising a gene which complements a deficiency in the host cell. The host cell is a strain having a deficiency in a function necessary for normal cell growth. The gene in the DNA molecule, such as a plasmid, which complements the deficiency serves as a selection maker whereby the growth conditions for selection may comprise a conventional complex medium.
Patent DE-3781922-T2 (DE)
Inventor: SAINIO JEFFREY W
IPC: B41F33/00
Filed: 1987-04-03
Granted: 1993-02-18
Abstract: A system for maintaining registry between a plurality of printing units (102-105), cooperating with a moving web (110), the system being of the type wherein the printing units (102-105) include means, (116, 117, 118, 119) for placing respective registration marks (202, 203, 204, 205, 206) on the web (110), the relative positions of the marks (202, 203, 204, 205, 206) being indicative of registry between the printing units (102-105), and further including means (126) responsive to control signals applied thereto for adjusting the registry of the printing units (102-105), and means for generating control signals to the registry adjusting means (126) in accordance with the relative positions of the registration marks (202, 203, 204, 205, 206). Registration marks (202, 203, 204, 205, 206) include a portion having symmetrical sides diagonal to the direction of the web motion.
Patent DE-3782195-T2 (DE)
Inventor: SORENSEN JAY RANDALL
IPC: A61B5/022
Filed: 1987-06-29
Granted: 1993-02-25
Abstract: An ambulatory blood pressure monitor comprises a cuff (104) coupled by a single fluid passageway to a manifold (202) which in turn is coupled to a pump (102), valve (112) and pressure transducer (110). The manifold comprises a larger main chamber (360) in fluid communication with a smaller secondary chamber (362) through a small channel (370) in a wall separating the chambers. The pump, cuff and valve are in fluid communication with one another directly through the main chamber while the pressure transducer is coupled to the cuff through the secondary chamber.
Patent DE-3786660-T2 (DE)
Inventor: BEALKOWSKI RICHARD
IPC: G06F12/10
Filed: 1987-12-15
Granted: 1994-02-17
Abstract: A computer system and method for operating a computer system capable of running in mutually incompatible real and protected addressing modes, in which programs written for one mode can be run in the other mode without modification. The BIOS assembles two different common data areas for the two modes, each inclusive of device block pointers, function transfer table pointers, data pointers, and function pointers. The common data area for the real mode is assembled first. To assemble the pointers for the protected mode common data area, the offset values from the real mode area are copied directly, and then selector values are inserted whose physical addresses correspond to the segments of the corresponding pointers in the real mode area. The selector values are derived from a segment descriptor table.
Patent DE-3873061-T2 (DE)
Inventor: HOSOKAWA JUN
IPC: D21H17/14
Filed: 1988-12-21
Granted: 1992-12-03
Abstract: The composite material of the invention is a sheet of cellulose fibres impregnated with chitosan of at least 40% deacetylation and further impregnated with a higher fatty acid such as stearic acid by treatment with an organic solution thereof. The composite sheet of the invention differs from conventional paper and films of plastic resins in having a high strength even in a wet condition and still is biodegradable, for example, in wet soils so that no problems of environmental pollution are caused by the waste thereof left in the environment. Therefore, the composite sheet of the invention is useful as a wrapping material for foods, a sheet material for agricultural use and other temporary or seasonal uses.
Patent DE-3873349-T2 (DE)
Inventor: MAGID HILLEL
IPC: C10N20/02
Filed: 1988-10-12
Granted: 1993-04-22
Abstract: Compression refrigeration equipment using tetrafluoroethane as a working fluid employs polyoxyalkylene glycols which are at least difunctional with respect to hydroxyl groups and a molecular weight between 300 and 2000. The mixtures of the glycols with the refrigerant will be miscible in the range from -40 DEG  C. to at least + 20 DEG  C.
Patent DE-3880649-T2 (DE)
Inventor: CALLEMYN JEAN-MICHEL
IPC: G06F13/18
Filed: 1988-12-19
Granted: 1993-10-28
Abstract: Control of the access priorities to a memory is characterised in that each requesting module (DP, GP) separately formulates the single-word access requests (DPREQ1, GPREQ1) and the multi-word access requests (DPREQN, GPREQN); different priorities (REGA, REGB, REGC, REGD) can then be assigned (VALREG) to each request type. Advantageously the single-word requests are arbitrated by a first module which transmits a selected request to a second module. <IMAGE>
Patent DE-3881012-T2 (DE)
Inventor: SCHMELZER HANS-GEORG
IPC: C07C209/72
Filed: 1988-12-31
Granted: 1993-10-14
Abstract: The present invention is directed to a process for the catalytic hydrogenation of a starting material containing 4,4 min -diamino-diphenylmethane (4,4 min -MDA) or its mixtures with 2,4 min -diamino-diphenylmethane, 2,2 min -diamino-diphenylmethane and/or higher ring compounds of the diphenylmethane series to a hydrogenation product having a trans-trans isomer content of 4,4 min -diamino-dicyclohexylmethane (4,4 min -HMDA) of about 15 to 40 weight percent, based on the diamine content of the hydrogenated product, by continuously hydrogenating in at least one fixed bed reactor at a temperature of about 100 to 190 DEG C and a pressure of about 50 to 350 bar in the presence of a ruthenium catalyst on a catalyst support having a BET surface area of about 70 to 280 m<2>/g and an average pore diameter dp of about 10 to 320  ANGSTROM , the catalyst being prepared by impregnating the catalyst support to a penetration depth of at least about 50  mu m with a soluble ruthenium compound in an amount sufficient to provide a catalyst containing about 0.1 to 5 weight percent ruthenium and subsequently reducing the soluble ruthenium compound to ruthenium.
Patent TR-199802404-T2 (TR)
Inventor: CHEN JIN LING
IPC: A01N61/00
Filed: 1997-05-19
Abstract: Özellikle yapraklara uygulamak için uygun olan poliüre mikrokapsüller, içinde poliürenin bir aromatik diizosiyanat ve istege bagli olarak üç ya da daha fazla izosiyanat grubuna sahip bir aromatik poliizosiyanat'tan olusturuldugu ara yüzeye dair polimerizasyon süreci ile hazirlanir.Burada poliizosiyanat: diizosiyanat agirlik orani (her iki türden izosiyanat da mevcut oldugu zaman) yaklasik 1:100 ile yaklasik 1:15 arasinda degisir ve yaklasik 1 ile yaklasik 5 mikronluk ortalama partikül boyutlarina sahip mikrokapsüller imal edilir.Bilinen sivi  pestisid kompozisyonlari (örn. sübyelestirilebilir konsantre) ile karsilastirildiginda mikrokapsüller daha güvenli sekilde idare edilir ve daha fazla aktif madde yüklenebilir ve bu arada sivi kompozisyonlara denk biyolojik aktivite elde edilebilir.
Patent TR-199902031-T2 (TR)
Inventor: WEISBURN JAMES T
IPC: E05B73/00
Filed: 1998-02-18
Abstract: Büyük (4) ve küçük (5) bölmeleri olan dörtgensel maddeleri güvenli biçimde saklamak ve görüntülemek için tekrar kullanilabilir plastik paket (1). Büyük bölmede parçayi bölmenin içine sokmak ve çikarmak için bir giris açikligi bulunmaktadir. Küçük bölme, bölmenin üzerine kayabilir sekilde monte edilmiss ve parçayi, serbest birakilabilir sekilde büyük saklama bölmesinin içinde emniyete almak için giris araliginin bir kismi boyunca istege bagli olarak hareket ettirilebilir bir kilit plakasi (3) ile kilit bölmesi olarak is görmektedir. Manyetik olarak serbest birakilabilir kilitleme kollari (35,36), kilit plakasi bir konumda kilitlendiginde, kilit plakasi (3) üzerinde olusan birbirine geçme projeksiyonlarla (52,53) ilgilidir.
Patent AT-E418979-T2 (AT)
Inventor: PFLAUM ZLATKO
IPC: A61K31/00
Filed: 2000-06-09
Granted: 2009-01-15
Abstract: Lovastatin, pravastatin, simvastatin, mevastatin, atorvastatin, and derivatives and analogs thereof are known as HMG-CoA reductase inhibitors and are used for the treatment of hypercholesterolemia and hyperlipidemia. The majority of them are produced by fermentation using microorganisms of different species identified as species belonging to Aspergillus, Monascus, Nocardia, Amycolatopsis, Mucor or Penicillium genus, and some are obtained by treating the fermentation products using the methods of chemical synthesis or they are the products of total chemical synthesis. The aforementioned active substances may be destabilised by the environmental factors, their degradation may also be accelerated by interactions with other pharmaceutical ingredients, such as fillers, binders, lubricants, glidants and disintegrating agents, therefore the pharmaceutical ingredients and the process for preparation of the pharmaceutical formulation should be meticulously chosen to avoid the aforementioned undesired interactions and reactions. The present invention relates to a product or a pharmaceutical package or administration material which contains a HMG-CoA reductase inhibitor or a pharmaceutical formulation in a stable manner.
Patent DE-60000542-T2 (DE)
Inventor: GIOVANARDI UMBERTO
IPC: B28B13/02
Filed: 2000-07-25
Granted: 2003-06-26
Abstract: In the process and apparatus of the invention, a layer of powders (8) bearing patterns is laid on a rest surface of a belt conveyor (7), the conveyor belt is introduced between the bottom die (2) and the top die (3) above a cell (4) afforded in the bottom die (2), the layer of powders (8) is unloaded into the cell (4) by a swift withdrawal of the belt conveyor (7). The withdrawal of the unloading end of the conveyor belt is carried out with no relative dragging between the rest surface and the bottom of the layer of powders (8), by means of a translation which is parallel to the rest surface and which is very rapid. <IMAGE>
Patent DE-60000801-T2 (DE)
Inventor: ANGAROLA BARRY R
IPC: F16K31/524
Filed: 2000-03-10
Granted: 2003-07-03
Abstract: A collar actuatable air valve especially for air powered strap tensioning tools (100) include a collar (130) rotatably coupled to a housing (120), an air valve (10) disposed at least partially in the housing (120) and having an actuator portion (14) biased to protrude therefrom and into engagement with an actuator surface (134,136) of the collar (130). A collar biasing member (150) rotatably biases the collar (130) relative to the housing (120) to close the air valve (10), whereby the collar (130) is rotatable against the bias of the collar biasing member (150) to open the air valve (10). <IMAGE>
Patent DE-60004003-T2 (DE)
Inventor: ARNAUD PASCAL
IPC: A61K8/34
Filed: 2000-11-29
Granted: 2004-06-03
Abstract: The present invention provides a composition, which includes: at least one volatile hydrocarbon-based solvent; at least one non-volatile silicone compound which is soluble or dispersible in the volatile hydrocarbon-based solvent; and at least one non-volatile hydrocarbon-based oil which is soluble in the volatile hydrocarbon-based solvent and incompatible with the non-volatile silicone compound; wherein the non-volatile hydrocarbon-based oil has solubility parameters satisfying the relationships, 16.40 (J/cm3)½<=deltaD<=19.00 (J/cm3)½ and 2.00 (J/cm3)½<=deltaa<=9.08 (J/cm3)½. Other embodiments of the present invention provides methods of making and using the above-noted composition, as well as compositions that include the above-noted composition. By the present invention, it is possible to obtain a glossy deposit having very good staying power, which undergoes little or no transfer, does not migrate and is water-resistant, while at the same time being very pleasant to apply and to wear throughout the day.
Patent DE-60004199-T2 (DE)
Inventor: PEREMANS ANDRE
IPC: H01S3/109
Filed: 2000-05-03
Granted: 2004-04-15
Abstract: The invention relates to a device for a laser blocked-mode, especially for a pulsed laser, comprising a cavity resonator ( 20 ) which is defined by a first mirror ( 1 ) and a second mirror ( 8 ), and fitted with an amplifying active laser medium ( 5 ) for the amplification of a beam of laser radiation of a fundamental frequency (omega1) and a solid, non-linear optic means ( 10 ) comprising at least said second mirror ( 8 ) for reversible conversion of the radiation of the fundamental frequency (omega1) into radiation of a harmonic frequency (omega2) whereby said non-linear optic means ( 10 ) has a reflection factor which increases with the intensity of the radiation of a fundamental frequency. The invention is characterized in that said device also comprises a solid intensity limiter ( 4 ) in the cavity resonator ( 20 ), whereby the transmission factor of the laser radiation decreases with the intensity of said radiation. The invention also relates to a method for a laser blocked-mode, especially for a pulsed laser, using said device.
Patent DE-60012575-T2 (DE)
Inventor: PEDRANI MASSIMO
IPC: A61K9/00
Filed: 2000-12-21
Granted: 2005-07-21
Abstract: Anhydrous gels containing non-steroid anti-inflammatory drugs for the administration of said drugs in analgesic therapy and in the prevention and treatment of stomatological and buccal inflammatory diseases, are capable of adhering to the mucosae of the absorption site, thereby promoting high absorption of the active ingredient in areas which are difficult to reach by systemic administration, if not through very large dosages.